MedPath

Retrospective Analysis of Balloon Expandable Covered Stenting in the Common Femoral Artery

Completed
Conditions
Vascular Complications
Registration Number
NCT05220540
Lead Sponsor
Semmelweis University Heart and Vascular Center
Brief Summary

The aim of this study is to evaluate the safety and efficacy of balloon expandable covered stenting of access complications, stenoses or pseudoaneurysms of the common femoral access.

Detailed Description

In the past decades, there has been a paradigm shift in the field of vascular surgery, with endovascular interventions replacing traditional open surgical procedures on an increasing scale. Most of these interventions are performed via the femoral artery. Even with modern percutaneous vascular closure devices, interventional laboratories report a high incidence of vascular complications, most commonly bleeding. Interventional procedures are gaining ground as an alternative to surgery. Having regard to the fact that femoral arteries are in constant motion due to their location and are subject to intense bending forces, the long-term durability of stents has been questioned in the absence of long-term follow-up data. There is currently no broad consensus on the strategy of care for vascular complications, and overall the decision is left to the discretion of the interventionalist, largely determined by the available local resources and infrastructure. The use of covered stents is an option for endovascular treatment of the complications: the self expanding nitinol framed stent graft with polytetrafluoroethylene (PTFE) coating and the cobalt-chrome framed, also PTFE coated balloon expandable stent. The main aim of this research is to analyse the short- and long-term outcome of these alternatives.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • over 18 years of age
  • intervention from the left or right common femoral artery
  • access complication treated by balloon expandable covered stent(s) or common femoral artery disease treated by balloon-expandable covered stent(s)

Exclusion criteria:

  • none
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reintervention rate1 year

Number of reinterventions on the treated vessels

Primary patency rate1 year

Number of patent common femoral arteries at one year

Amputation rate1 year

Number of amputations at the side of the treated common femoral artery

Secondary Outcome Measures
NameTimeMethod
Restenosis rate1 year

Number of significant (peak systolic velocity ratio \> 2,4) restenoses found at one year

Walking disturbance rate1 year

Number of any new onset walking impairment

Trial Locations

Locations (3)

University of Szeged, Albert Szent-Györgyi Health Center, Second Department of Medicine and Cardiology Centre

🇭🇺

Szeged, Csongrád-Csanád, Hungary

Semmelweis University Heart and Vascular Center

🇭🇺

Budapest, Hungary

Gottsegen National Cardiovascular Center

🇭🇺

Budapest, Hungary

© Copyright 2025. All Rights Reserved by MedPath